Prestige Brands Holdings, Inc. (NYSE:PBH) posted its results for fiscal second-quarter.
Earnings for the quarter surged 53% on revenue growth of 49%, company topped analysts' expectations. The seller of brands such as Chloraseptic sore throat treatments, Clear Eyes eye-care products and Compound W wart treatments also improved per share earnings guidance.
For the six month period total revenue was $308.9 million, which is an upsurge of 53.8% over the previous six month period's revenues of $200.8 million.
Prestige Brands Holdings, Inc. (NYSE:PBH) traded with volume of 665,800 shares in last session which was unexpectedly higher versus average trading capacity of 218,013 shares. The stock traded with opening bell at $17.57, gained the maximum price level of $20.92 and then finished the day at $20.60 by scoring 18.46%.
PBH remained successful in generating revenue of $492.79 million in the trailing twelve months and made net income of $37.10 million. The Company maintained a positive 7.53% for the net profit margin and in its operating margin it scored 23.14%. Company’s yearly revenue change for the last five years was 8.30%.
The PBH’s price to sales ratio is 2.11 and price to cash ratio is 236.29 for the past 12 months. As far as the returns from the company is concerned, return on assets remained as 2.65%.
The stock showed upbeat performance of 20.89% for the week which was maintained for the month at 20.47%. Likewise the positive performance for the trailing 3 months was recorded as 31.38% and in last year was 94.71% while the performance so far in current year remains at 82.79%.
Disclaimer
Fast Moving Stock does not own any shares or plan to get a position(s) in the company(s) anytime soon. Moreover, we have not been compensated for the posting of this article/report/analysis, as this is just an opinion of our writer/contributor. Not recommandation to buy or sell any stocks Read full
